Machine signal
Active cluster sell — 4 distinct insiders, $3.7M, window ends Oct 1, 2026.
Figures computed from official regulatory filings — .
Analysttarget 108.67 USD (+92%) · consensus 4.73/5 · 10 buy · 1 hold · 0 sell
Ownershipinsiders 0.5% · institutions 113.48% · short 10.9% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Vaxcyte, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting the keystone pathogen responsible for periodontitis; VAX-GI, a novel preclinical vaccine candidate for the treatment of dysentery and shigellosis, which is caused by Shigella bacteria; and VAX-XL, a third-generation pneumococcal conjugate vaccine. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
4 buys554 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Wassil Jim | Sell | $5.4K | SEC | ||
| Wassil Jim |
| Exercise |
| $12K |
| SEC |
| Wassil Jim | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Wassil Jim | Sell | $122.1K | SEC |
| Wassil Jim | Sell | $79.4K | SEC |
| Dhaliwal Harpreet S. | Other | $461.8K | Unusual size | SEC |
| Cowan Elvia | Other | $80.1K | SEC |
| PICKERING GRANT | Other | $1M | SEC |
| Jodar Luis | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Wassil Jim | Other | $329.5K | SEC |
| Wassil Jim | Sell | $84.5K | SEC |
| GUGGENHIME ANDREW | Other | $431.9K | SEC |
| Jodar Luis | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Dhaliwal Harpreet S. | Other | $40.6K | SEC |
| Dhaliwal Harpreet S. | Other | $21.9K | SEC |
| Cowan Elvia | Other | $20.1K | SEC |
| Wassil Jim | Sell | $43.8K | SEC |
| Wassil Jim | Sell | $56.3K | SEC |
| GUGGENHIME ANDREW | Other | $88.2K | SEC |
| Wassil Jim | Other | $77.3K | SEC |
| Wassil Jim | Sell | $93.6K | SEC |
| GUGGENHIME ANDREW | Other | $77.3K | SEC |
| Wassil Jim | Sell | $18.6K | SEC |
| Wassil Jim | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| PICKERING GRANT | Other | $173.8K | SEC |